Reuters logo
BRIEF-Cardio3 Biosciences announces new business development strategy
October 1, 2014 / 5:53 AM / in 3 years

BRIEF-Cardio3 Biosciences announces new business development strategy

Oct 1 (Reuters) - Cardio3 Biosciences Sa

* Cardio3 biosciences announces new business development strategy to broaden its product pipeline

* Strategy aims to expand company`s product portfolio and generate multiple short term value creation milestones

* Strategy will be articulated around a technology pillar - cellular therapies - and a clinical application pillar - cardiovascular diseases Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below